Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $861.16 | 36 | 98.4% |
| Education | $13.60 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $263.54 | 4 | $0 (2024) |
| Amgen Inc. | $138.60 | 4 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $80.02 | 5 | $0 (2024) |
| Relypsa, Inc. | $54.92 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $53.62 | 3 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $49.38 | 3 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $36.78 | 2 | $0 (2024) |
| Calliditas Therapeutics US Inc. | $33.35 | 2 | $0 (2023) |
| Ardelyx, Inc. | $32.24 | 2 | $0 (2024) |
| Vifor Pharma, Inc. | $24.87 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $297.66 | 13 | Amgen Inc. ($113.21) |
| 2023 | $194.32 | 11 | Aurinia Pharma U.S., Inc. ($48.44) |
| 2022 | $30.76 | 2 | Fresenius USA Marketing, Inc. ($17.06) |
| 2020 | $122.19 | 1 | Otsuka America Pharmaceutical, Inc. ($122.19) |
| 2019 | $147.87 | 4 | Otsuka America Pharmaceutical, Inc. ($106.36) |
| 2018 | $54.93 | 4 | Relypsa, Inc. ($26.95) |
| 2017 | $27.03 | 2 | Arbor Pharmaceuticals, Inc. ($13.76) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $16.83 | General |
| 10/22/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Cardio-renal | ||||||
| 10/08/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: NEPHROLOGY | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Immunology | ||||||
| 08/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $96.69 | General |
| Category: Inflammation | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.50 | General |
| 03/20/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: NEPHROLOGY | ||||||
| 03/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/05/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.90 | General |
| 03/01/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/12/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $13.97 | General |
| 12/11/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Education | Cash or cash equivalent | $13.60 | General |
| Category: Nephrology | ||||||
| 10/25/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/16/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/14/2023 | FRESENIUS USA MANUFACTURING, INC. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/02/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Nephrology | ||||||
| 06/26/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/29/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Cardio-renal | ||||||
| 02/08/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Hyperkalemia | ||||||
| 10/24/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 471 | 891 | $155,050 | $82,954 |
| 2022 | 9 | 552 | 942 | $168,525 | $86,039 |
| 2021 | 10 | 615 | 1,060 | $198,927 | $107,570 |
| 2020 | 7 | 459 | 816 | $175,635 | $78,494 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 105 | 256 | $62,720 | $36,097 | 57.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 164 | 296 | $53,280 | $29,428 | 55.2% |
| 99091 | Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | Office | 2023 | 132 | 269 | $24,210 | $11,979 | 49.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $7,040 | $4,009 | 56.9% |
| 93784 | Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | Office | 2023 | 24 | 24 | $6,600 | $945.12 | 14.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 24 | 24 | $1,200 | $495.36 | 41.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 116 | 252 | $61,740 | $36,292 | 58.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 263 | $47,340 | $24,799 | 52.4% |
| 99091 | Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | Office | 2022 | 131 | 251 | $22,590 | $11,789 | 52.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 48 | $12,480 | $4,306 | 34.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $5,980 | $3,687 | 61.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 56 | $10,360 | $3,435 | 33.2% |
| 93784 | Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | Office | 2022 | 21 | 21 | $5,775 | $770.83 | 13.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 11 | $1,210 | $559.71 | 46.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 21 | 21 | $1,050 | $400.64 | 38.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 113 | 296 | $72,520 | $44,879 | 61.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 173 | 335 | $60,300 | $35,119 | 58.2% |
| 99091 | Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | Office | 2021 | 117 | 175 | $15,182 | $8,542 | 56.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 50 | 68 | $17,680 | $6,188 | 35.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 60 | 82 | $15,170 | $5,083 | 33.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 26 | 26 | $8,060 | $4,939 | 61.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 14 | $1,540 | $1,141 | 74.1% |
| 93784 | Ambulatory blood pressure monitoring, 24 hours or longer, with recording, scanning analysis, interpretation, and report | Office | 2021 | 25 | 25 | $6,875 | $1,028 | 15.0% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 25 | 25 | $1,250 | $518.25 | 41.5% |
| 99474 | Self-measured blood pressure measurements | Office | 2021 | 14 | 14 | $350.00 | $133.00 | 38.0% |
About Dr. Michael Ruddy, M.D
Dr. Michael Ruddy, M.D is a Specialist healthcare provider based in Princeton Junction, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831138015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ruddy, M.D has received a total of $874.76 in payments from pharmaceutical and medical device companies, with $297.66 received in 2024. These payments were reported across 37 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($861.16).
As a Medicare-enrolled provider, Ruddy has provided services to 2,097 Medicare beneficiaries, totaling 3,709 services with total Medicare billing of $355,057. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Princeton Junction, NJ
- Active Since 06/05/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1831138015
Products in Payments
- JYNARQUE (Drug) $263.54
- TAVNEOS (Drug) $96.69
- LUPKYNIS (Drug) $80.02
- Veltassa (Drug) $79.79
- Velphoro (Drug) $68.41
- Kerendia (Drug) $36.78
- TARPEYO (Drug) $33.35
- IBSRELA (Drug) $32.24
- Parsabiv (Biological) $25.39
- KRYSTEXXA (Biological) $16.52
- JARDIANCE (Drug) $15.87
- ACTHAR (Biological) $14.28
- Fabhalta (Drug) $14.22
- Edarbi (Drug) $13.76
- FARXIGA (Drug) $13.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Princeton Junction
Vadim Finkielstein, M.d, M.D
Specialist — Payments: $175,531
Grace Bialy, M.d, M.D
Specialist — Payments: $1,947
Seema Basi, Md, MD
Specialist — Payments: $1,680
Dr. Rajiv Patel, Md Phd, MD PHD
Specialist — Payments: $993.41
Mr. William Serverson, A.t.c, A.T.C
Specialist
Mrs. Carol Foster, Ms, Otrl, MS, OTRL
Specialist